Recap: Maravai LifeSciences Q2 Earnings - Maravai LifeSciences (NASDAQ:MRVI)

Maravai LifeSciences MRVI reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Maravai LifeSciences beat estimated earnings by 20.0%, reporting an EPS of $0.54 versus an estimate of $0.45.

Revenue was up $24.96 million from the same period last year.

Last quarter the company beat on EPS by $0.1 which was followed by a 13.38% increase in the share price the next day.

Here's a look at Maravai LifeSciences's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	0.44	0.38	0.35	0.31
EPS Actual	0.54	0.45	0.44	0.44
Revenue Estimate	232.30M	208.09M	201.50M	192.29M
Revenue Actual	244.29M	228.44M	204.81M	217.78M

To track all earnings releases for Maravai LifeSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.